###begin article-title 0
###xml 142 149 142 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 153 156 153 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt</italic>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Pancreatic islet expression profiling in diabetes-prone C57BLKS/J mice reveals transcriptional differences contributed by DBA loci, including Plagl1 and Nnt
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lepr</italic>
###xml 189 193 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lepr</italic>
###xml 193 198 193 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">db/db</sup>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
C57BLKS/J (BLKS) mice are susceptible to islet exhaustion in insulin-resistant states as compared with C57BL6/J (B6) mice, as observed by the presence of the leptin receptor (Lepr) allele, Leprdb/db. Furthermore, DBA2/J (DBA) mice are also susceptible to beta-cell failure and share 25% of their genome with BLKS; thus the DBA genome may contribute to beta-cell dysfunction in BLKS mice.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 513 515 513 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 521 524 521 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-27</sup>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
Here we show that BLKS mice exhibit elevated insulin secretion, as evidenced by improved glucose tolerance and increased islet insulin secretion compared with B6 mice, and describe interstrain transcriptional differences in glucose response. Transcriptional differences between BLKS and B6 mice were identified by expression profiling of isolated islets from both strains. Genomic mapping of gene expression differences demonstrated a significant association of expression differences with DBA loci in BLKS mice (P = 4x10-27).
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 11 52 11 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nicotinamide nucleotide transhydrogenase </italic>
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt</italic>
###xml 62 95 62 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pleiomorphic adenoma gene like 1 </italic>
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1</italic>
###xml 304 308 304 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 391 398 391 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
###xml 735 739 <span type="species:ncbi:10090">mice</span>
Two genes, Nicotinamide nucleotide transhydrogenase (Nnt) and Pleiomorphic adenoma gene like 1 (Plagl1), were 4 and 7.2-fold higher respectively in BLKS islets, and may be major contributors to increased insulin secretion by BLKS islets. Contrary to reports for B6 mice, BLKS mice do not harbor a mutant Nnt gene. We detected 16 synonymous polymorphisms and a two-amino acid deletion in the Plagl1 gene in BLKS mice. Several inflammatory glucose-responsive genes are expressed at a higher level in BLKS, suggesting an inflammatory component to BLKS islet dysfunction. This study describes physiological differences between BLKS and B6 mice, and provides evidence for a causative role of the DBA genome in beta-cell dysfunction in BLKS mice.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 217 218 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 637 640 625 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob </italic>
###xml 687 688 675 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 886 887 874 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
###xml 590 594 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
Type 2 diabetes mellitus can be considered as a two-stage disease. First the body becomes resistant to circulating insulin, and second, when coupled with pancreatic beta-cell dysfunction, overt diabetes precipitates [1]. Insulin resistance alone, without beta-cell exhaustion, will not lead to hyperglycemia. In this case the islet compensates by increasing insulin production and beta-cell populations are maintained. Differences in beta-cell adaptation to increased insulin demand likely reflect an underlying genetic component. Indeed, in B6 mice, but not in genetically dissimilar BTBR mice, insulin resistance induced by the leptin ob allele is well compensated by islet expansion [2]. The genetic alteration in BTBR mice which underpins this failure to adapt to increased insulin requirements was recently identified and localized to a gene contributing to islet vascularization [3].
###end p 9
###begin p 10
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lepr</italic>
###xml 11 16 11 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">db/db</sup>
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lepr</italic>
###xml 178 183 178 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">db/db</sup>
###xml 532 533 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 872 876 <span type="species:ncbi:10090">mice</span>
Obese (Leprdb/db) B6 and 129/J mice are insulin resistant but compensate this potentially pathogenic process by islet hypertrophy and hyperinsulinemia [4,5]. However, obese (Leprdb/db) DBA mice not only develop insulin resistance but also severe diabetes due to beta-cell loss. Thus the DBA background may be considered a diabetogenic strain exhibiting a predisposition to beta-cell failure. DBA mice copiously secrete insulin (10-fold over basal) in response to a glucose bolus compared with a modest (3-fold) increase in B6 mice [6]. This hypersecretion phenotype (here after referred to as elevated insulin secretion) is retained in isolated islets, and confirms a functional difference between these two strains specific to the islet. These data suggest that elevated secretion of insulin may be deleterious to the beta cell and results in beta-cell exhaustion in DBA mice.
###end p 10
###begin p 11
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob </italic>
###xml 89 97 89 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db Lepr </italic>
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 417 418 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 419 421 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 487 491 484 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lepr</italic>
###xml 491 497 488 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink">db/db </sup>
###xml 511 515 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lepr</italic>
###xml 515 521 512 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">db/db </sup>
###xml 5 9 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
BLKS mice also exhibit pancreatic islet failure when made insulin resistant by the ob or db Lepr alleles [5,7,8], as evidenced by gross islet atrophy and beta-cell loss. This strain is closely related to B6; however, it harbors a small contribution from the DBA strain. Genetic analysis of the BLKS mice has uncovered a contribution of approximately 71% from B6, 25% from DBA, and 4% from other strains in BLKS mice [9-11]. Given the clear differences in severity of diabetes between B6-Leprdb/db mice and BLKS-Leprdb/db mice, and the similarity between BLKS and DBA mice, it is tempting to speculate that islet sensitivity may be conferred by alleles from the DBA genome.
###end p 11
###begin p 12
###xml 642 647 642 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Txnip</italic>
###xml 648 652 648 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lnc2</italic>
###xml 653 665 653 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gad1 Slc7a3 </italic>
###xml 669 673 669 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spp1</italic>
###xml 734 738 734 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 742 749 742 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
In this report we investigated islet function in non-obese B6 and BLKS mice. We found that BLKS mice are profoundly more glucose tolerant than B6 and this difference was associated with elevated secretion of insulin in islets. We investigated the differences in gene expression in isolated islets between the two strains, in both basal and stimulated (insulin secretion stimulated) conditions, and found that 75% of the gene expression differences in the BLKS islets were contributed from genes within DBA loci. Further, several genes regulated by glucose in both strains suggest early inflammatory effects associated with increased glucose (Txnip,Lnc2,Gad1 Slc7a3 and Spp1). Notably, we identified significantly higher expression of Nnt and Plagl1 (ZAC1) in BLKS islets, two genes previously associated with islet dysfunction.
###end p 12
###begin title 13
Results and discussion
###end title 13
###begin title 14
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Glucose homeostasis in non-obese BLKS and B6 mice
###end title 14
###begin p 15
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lep</italic>
###xml 69 75 69 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">db/db </sup>
###xml 417 421 415 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs. </italic>
###xml 500 504 494 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs. </italic>
###xml 699 701 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 786 788 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 861 863 853 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1211 1213 1203 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 2151 2153 2143 2145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 557 561 <span type="species:ncbi:10090">mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
###xml 725 729 <span type="species:ncbi:10090">mice</span>
###xml 815 819 <span type="species:ncbi:10090">mice</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
###xml 1041 1045 <span type="species:ncbi:10090">mice</span>
###xml 1268 1272 <span type="species:ncbi:10090">mice</span>
###xml 1329 1333 <span type="species:ncbi:10090">mice</span>
###xml 1453 1457 <span type="species:ncbi:10090">mice</span>
###xml 1499 1503 <span type="species:ncbi:10090">mice</span>
###xml 1627 1631 <span type="species:ncbi:10090">mice</span>
###xml 1669 1673 <span type="species:ncbi:10090">mice</span>
###xml 1689 1693 <span type="species:ncbi:10090">mice</span>
###xml 1865 1869 <span type="species:ncbi:10090">mice</span>
###xml 2033 2037 <span type="species:ncbi:10090">mice</span>
###xml 2201 2205 <span type="species:ncbi:10090">mice</span>
Although glucose homeostasis has been extensively studied in BLKS-Lepdb/db mice, few reports have shown clear differences in non-obese BLKS mice compared with B6 mice. To better understand the differences between both these strains, we analyzed fasting glucose in young (12 weeks old) and aged (26 weeks old) mice. At 12 weeks of age, fasting glucose levels between B6 and BLKS mice were similar (113.3 +/- 5.7 mg/dL vs. 100.7 +/- 3.6 mg/dL, respectively) as well as at 26 weeks (118.4 +/- 4.2 mg/dL vs. 111.0 +/- 17 mg/dL). Interestingly, B6 mice and BLKS mice have similar body weights at younger ages but after 16 weeks of age the B6 mice continue to gain weight whereas BLKS mice do not (Figure 1A). Also, in 12-week-old-mice insulin levels were the same in the two strains (Figure 1B). However, at 26 weeks B6 mice had significantly higher insulin levels (P = 0.018) than BLKS mice, and could reflect the difference in body weights. We found no differences in glucagon levels (data not shown). The difference in insulin levels in older mice may also represent a difference in glucose homeostasis. To investigate this further, glucose tolerance tests (GTTs) were performed at 10 and 23 weeks of age (Figure 1B). At both ages, glucose tolerance between B6 and BLKS mice was clearly different. Although 10-week-old B6 and BLKS mice had similar basal fasting blood glucose levels, at 30, 60 and 120 min after an intraperitoneal injection of glucose B6 mice were less glucose tolerant than the BLKS mice. Similar results were obtained at 23 weeks of age; however, at this age the basal fasted blood glucose values for the BLKS mice were statistically lower than the B6 mice. Both lines of mice were more glucose intolerant at 23 weeks than at 10 weeks of age (blood glucose spike at 30 min was increased in both strains). The glucose intolerance observed in the B6 mice at 23 weeks could be related to the higher body weight and some degree of peripheral of insulin resistance. On the other hand, the younger B6 and BLKS 10-week-old mice had similar body weights yet clearly were dissimilar in glucose tolerance; furthermore, a report by Goren et al [12] illustrated that 8 to 10-week-old B6 and BLKS mice are very similar when challenged in an insulin tolerance test. Taken together, we interpret these data to reflect a pancreatic difference between these two strains to account for the differences in glucose tolerance.
###end p 15
###begin p 16
###xml 0 39 0 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Glucose homeostasis in B6 and BLKS mice</bold>
###xml 84 86 84 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 215 217 215 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 236 238 236 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 487 488 487 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 524 526 524 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 537 539 537 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 551 553 551 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
Glucose homeostasis in B6 and BLKS mice. (A) Body weights of B6 and BLKS male mice (n = 13 for each strain) were monitored from 10 weeks to 26 weeks of age. (B) Fasting (4 h) plasma insulin was analyzed in 10-week (n = 13) and 23-week (n = 8) -old B6 and BLKS male mice. (C) Glucose tolerance was assessed in 10 and 23-week-old B6 and BLKS male mice, following an intraperitoneal injection of glucose (2 g/kg). All data represent means and s.e.m. and tested using a two-tailed Student's T-test assuming unequal variances; * P < 0.05, ** P < 0.01, *** P < 0.001.
###end p 16
###begin title 17
Islet insulin secretion and pancreatic immunohistochemistry
###end title 17
###begin p 18
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 436 437 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
To investigate if the enhanced glucose clearance in BLKS mice was attributed to increased insulin secretion, glucose-stimulated insulin secretion was measured in isolated islets from both B6 and BLKS mice (Figure 2A). Islets of BLKS mice secreted significantly more insulin than B6 mice at the higher glucose concentrations tested, providing further support for an elevated secretion phenotype. These data have been shown for DBA mice [6,13], but to date have not been reported for BLKS mice.
###end p 18
###begin p 19
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Insulin secretion is higher in BLKS mice than B6 mice</bold>
###xml 668 670 668 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 814 815 814 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 851 853 851 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 861 864 861 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n.s</italic>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 662 666 <span type="species:ncbi:10090">mice</span>
Insulin secretion is higher in BLKS mice than B6 mice. (A) Glucose-stimulated insulin secretion was investigated in isolated islets from 12-week-old B6 and BLKS male mice. Following 48 h recovery post-isolation, the islets were stimulated with 2, 10 or 16.7 mM glucose for 1 h. Insulin release into the media was monitored. (B) Immunohistochemistry was performed in pancreatic islets from 26-week-old male mice revealing no gross differences in islet appearance or size. Insulin (oxidized DAB-brown) and glucagon (Vector Blue product) expressing cells are shown. (C) Pancreatic insulin content was assessed in pancreata excised from 15-week-old male B6 and BLKS mice (n = 3/group). No statistically significant differences were detected. All data represent means and s.e.m. and tested using a two-tailed Student's T-test assuming unequal variances; * P < 0.05; n.s. not significant.
###end p 19
###begin p 20
###xml 464 466 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 730 732 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 864 868 <span type="species:ncbi:10090">mice</span>
###xml 960 964 <span type="species:ncbi:10090">mice</span>
To determine if the difference in insulin secretion correlated with differences in beta-cell mass, we performed histology and immunohistochemistry on pancreatic sections from both strains. No gross differences in islet number or appearance were observed in either B6 or BLKS mice as assessed in multiple mice of each strain. Furthermore, following staining for insulin and glucagon, a similar composition of alpha and beta cells within the islet was found (Figure 2B). Thus the difference in insulin secretion was not associated with any qualitative difference in beta-cell mass. To investigate if any quantitative differences in beta-cell mass were present between the two strains, we analyzed pancreatic insulin content (Figure 3C). Pancreata from BLKS mice were found to have a small but non-significant reduction in pancreatic insulin content compared with B6 mice. This, however, is unlikely to explain the elevated insulin secretion observed in the BLKS mice.
###end p 20
###begin p 21
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Plagl1 </italic>expression and genetic differences in BLKS mice</bold>
###xml 96 104 96 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1t </italic>
###xml 244 246 244 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 256 258 256 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 303 304 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 342 344 342 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 461 466 <span type="species:ncbi:10090">mouse</span>
Plagl1 expression and genetic differences in BLKS mice. (A) Quantitative RT-PCR analysis of the Plagl1t RNA in B6 and BLKS in isolated islet cultured in high glucose conditions. Data represent means and standard deviations of multiple mice (B6 n = 8; BLKS n = 4) and tested using a two-tailed Student's T-test assuming unequal variances; *** P < 0.001. (B) Diagram of the polypeptide structure of Plagl1 identifying the functional domains. Numbers refer to the mouse amino-acid positions, and letters refer to amino acids. The genetic differences between B6 and BLKS genes are shown by the stars; the two-amino acid deletion in BLKS is shown by the arrow.
###end p 21
###begin title 22
Islet gene expression differences between glucose concentrations
###end title 22
###begin p 23
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lepr</italic>
###xml 61 67 61 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">db/db </sup>
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lepr</italic>
###xml 90 96 90 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">db/db </sup>
###xml 1218 1219 1207 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1261 1262 1250 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
###xml 769 774 <span type="species:ncbi:10090">mouse</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
###xml 902 906 <span type="species:ncbi:10090">mice</span>
###xml 1018 1023 <span type="species:ncbi:10090">mouse</span>
Given that islet dysfunction is a characteristic of BLKS-Leprdb/db mice but not of B6-Leprdb/db mice, and is associated with heightened insulin secretion in non-obese BLKS mice, we hypothesized that these physiological outcomes may be reflected in differences in islet gene expression. We investigated gene expression in normal (non-diabetic) mice with the intention of analyzing expression in islets with similar compositions of alpha, beta, and delta cells. Furthermore, we speculated differences in gene expression may only become apparent after a period of extended secretion, which would expose genes involved in islet dysfunction/adaptation. To this end, islets were isolated from 10 B6 and 10 BLKS mice, and cultured for 2 days in 11 mM glucose (each individual mouse's islets were cultured separately). After this period, islets from five B6 mice were cultured in 5 mM glucose and from five B6 mice in 20 mM glucose for an additional 24 h. BLKS islets were treated similarly. RNA isolated from each individual mouse's islets was used to investigate global changes in gene expression between the strains in low and high-glucose conditions. We assessed the common differences due to glucose concentration (Table 1), and differences between strains (Table 2).
###end p 23
###begin p 24
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Gene expression fold-change differences in islets from low to high glucose in BLKS and B6 mice
###end p 24
###begin p 25
###xml 77 79 77 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
Genes are sorted for the subset with BLKS glucose response (fold change) >2 (p < 0.001, Benjamini-Hochberg FDR 0.8).
###end p 25
###begin p 26
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Gene expression fold-change differences in islets from BLKS mice compared with those from B6 mice
###end p 26
###begin p 27
###xml 73 75 73 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
Shown is the subset with fold change >2.5 under high glucose conditions (p < 0.001, Benjamini-Hochberg FDR 0.8). Genes are sorted by the interstrain fold difference in high glucose conditions.
###end p 27
###begin p 28
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 309 321 309 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lipocalin 2 </italic>
###xml 322 326 322 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lcn2</italic>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 587 595 587 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Leprotl1</italic>
###xml 694 699 694 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lcn2 </italic>
###xml 810 812 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 863 895 863 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glutamate decarboxylase 1 (Gad1)</italic>
###xml 966 968 966 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1077 1082 1074 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gad1 </italic>
###xml 1208 1214 1205 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S100a9</italic>
###xml 1335 1337 1332 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1338 1340 1335 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1387 1394 1384 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S100a9 </italic>
###xml 1433 1435 1430 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1471 1477 1468 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc7a3</italic>
###xml 1563 1570 1560 1567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc7a3 </italic>
###xml 1778 1780 1772 1774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 735 738 <span type="species:ncbi:10116">rat</span>
###xml 1099 1104 <span type="species:ncbi:10090">mouse</span>
###xml 1137 1141 <span type="species:ncbi:10090">mice</span>
###xml 1199 1203 <span type="species:ncbi:10090">mice</span>
###xml 1772 1776 <span type="species:ncbi:10116">rats</span>
Table 1 shows gene expression fold-change differences between low and high-glucose conditions in BLKS and B6 mice. We highlight the subset with BLKS glucose response of at least 2-fold. These transcriptional differences associated with glucose response in islets suggest an underlying inflammatory component. Lipocalin 2 (Lcn2) transcription increases 2.4-fold in response to higher glucose levels and is 2.07-fold higher in BLKS islets. This gene is regulated by the cytokine leptin in insulinoma cells [14] and interestingly BLKS mice also have 40% more of a specific leptin receptor (Leprotl1) at high glucose levels - 1.44 and 1.09-fold under high and low-glucose conditions, respectively. Lcn2 is also known to be up-regulated in rat models of type 2 diabetes, and associated with inflammatory functions [15] including apoptosis. The glucose-responsive gene Glutamate decarboxylase 1 (Gad1), which is an islet-derived autoantigen in insulin-dependent diabetes [16], may be a marker for beta-cell loss or toxicity and has been shown to be glucose responsive. We observed a Gad1 decrease in both mouse models, but more so in the BLKS mice. The gene with the largest change due to glucose in BLKS mice was S100a9. This gene is expressed in monocytes and pancreatic cell lines, and is essential for pancreatic leukocyte infiltration [17,18]. In addition to being an inflammatory marker S100a9 is associated with islet autoimmunity [19]. Another glucose-responsive gene, Slc7a3, is likely an indirect marker for the presence of resident islet inflammatory cells. Slc7a3 is a polar amino acid transporter, which provides L-arginine that can be used in nitric oxide (NO) production. NO synthesis and overproduction has been associated with beta-cell dysfunction in diabetic rats [20].
###end p 28
###begin p 29
###xml 115 147 115 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Thioredoxin interacting protein </italic>
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Txnip</italic>
###xml 181 187 181 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Txnip </italic>
###xml 249 251 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 309 315 306 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Txnip </italic>
###xml 610 616 607 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Txnip </italic>
###xml 685 687 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 767 773 764 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Txnip </italic>
###xml 953 959 950 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Txnip </italic>
###xml 978 984 975 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Txnip </italic>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 602 608 <span type="species:ncbi:9606">humans</span>
###xml 892 896 <span type="species:ncbi:10090">mice</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
###xml 967 971 <span type="species:ncbi:10090">mice</span>
###xml 1034 1038 <span type="species:ncbi:10090">mice</span>
In addition to the inflammation-associated genes we also observed strong induction by glucose of the gene encoding Thioredoxin interacting protein (Txnip) in both BLKS and B6 mice. Txnip has been recently linked with glucose-induced beta-cell loss [21]. Chen et al showed that glucose incubation up-regulated Txnip and increased apoptosis, which they speculated may be via the intrinsic mitochondrial apoptotic pathway. They also showed that constitutive over-expression is not necessary for apoptosis, but that the glucose-induced increase is sufficient. Furthermore, Parikh et al have shown that, in humans, Txnip over-expression reduces basal and insulin-stimulated glucose uptake [22], is elevated by glucose and suppressed by insulin. We confirm the increase of Txnip expression in response to glucose, although we do not observe any differential response to glucose between B6 and BLKS mice. On the contrary, BLKS mice have 2-fold lower levels of Txnip than B6 mice. Thus Txnip is unlikely to underlie the islet failure in BLKS mice, but more likely to represent the typical response to glucose.
###end p 29
###begin title 30
Islet gene expression differences between B6 and BLKS strains
###end title 30
###begin p 31
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 391 392 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 394 399 394 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spp1 </italic>
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 507 512 507 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spp1 </italic>
###xml 631 633 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 665 670 665 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spp1 </italic>
###xml 760 762 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 817 823 814 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc7a3</italic>
###xml 1030 1034 1027 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spp1</italic>
###xml 1056 1062 1053 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S100a9</italic>
###xml 1064 1069 1061 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aldob</italic>
###xml 1075 1083 1072 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc5a10 </italic>
###xml 1214 1216 1211 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1296 1300 1293 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs. </italic>
###xml 1320 1325 1317 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aldob</italic>
###xml 1400 1402 1397 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1409 1416 1406 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc5a10</italic>
###xml 1543 1547 1540 1544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs. </italic>
###xml 800 804 <span type="species:ncbi:10090">mice</span>
###xml 872 876 <span type="species:ncbi:10090">mice</span>
###xml 979 983 <span type="species:ncbi:10090">mice</span>
###xml 1142 1147 <span type="species:ncbi:10090">mouse</span>
###xml 1280 1284 <span type="species:ncbi:10090">mice</span>
###xml 1303 1307 <span type="species:ncbi:10090">mice</span>
###xml 1377 1382 <span type="species:ncbi:9606">human</span>
###xml 1506 1510 <span type="species:ncbi:10090">mice</span>
###xml 1552 1556 <span type="species:ncbi:10090">mice</span>
Table 2 shows a list of genes which were more than 2.5-fold different in BLKS islets compared with B6 islets in high glucose conditions (column 4, High Gluc.). All members of this list were significantly different between strains, regardless of glucose concentration, after controlling the false discovery rate at 0.80 [23]. In addition to its induction by glucose within each strain (Table 1) Spp1 expression is also significantly different between strains and is 3.5-fold higher in BLKS islets (Table 2). Spp1 or osteopontin is a multifunctional cytokine and a potential diagnostic predictor of diabetic end-stage renal disease [24]. Arafat et al have shown that Spp1 averts cytokine-mediated beta-cell toxicity through negative regulation of NO production [25]. As we have shown, both BLKS and B6 mice up-regulate Slc7a3, a gene associated with NO production, but BLKS mice always express higher levels (1.49 to 1.97-fold). Thus, the excess capacity for NO production in BLKS mice might counter the protective up-regulation of Spp1. Other genes such as S100a9, Aldob, and Slc5a10 demonstrate a stronger glucose response in only one of the mouse strains. S100a9, a diabetes-associated pro-inflammatory molecule [26], had a much larger increase due to increasing glucose in BLKS mice (4.3-fold) vs. B6 mice (1.6-fold). Aldob, encoding a glycolytic enzyme that is decreased in human diabetic islets [27], and Slc5a10, a sodium/glucose co-transporter, had stronger induction due to increasing glucose in B6 mice (1.5 and 3.5-fold respectively) vs. BLKS mice (1.1 and 1.6-fold respectively).
###end p 31
###begin p 32
###xml 11 12 11 12 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
From Table 2, 32 genes were more than 2.5-fold different in expression levels in BLKS islets compared with B6 islets; 16 genes were expressed at higher levels and 16 genes expressed at lower levels. Thirty of these genes displayed fold differences with magnitudes between 2.5 and 7.15. However, two genes had notable differences above this range.
###end p 32
###begin p 33
###xml 42 55 42 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6330403K07RIK</italic>
###xml 294 308 294 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6330403K07RIK </italic>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
The first, an uncharacterized transcript (6330403K07RIK), was 17.4-fold higher in BLKS islets. At this time, this gene's product has no assigned function and has no known homology to any protein. Interestingly, two protein sequences were identified from the NCBI gene database corresponding to 6330403K07RIK which had been translated from DBA genomic sequence and B6 mRNA sequence and were found to be different. The protein sequence from DBA mice (AAR87485) was different at four residues compared with the B6 sequence (BAB31072) over the 121 residues.
###end p 33
###begin p 34
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H2-Q1</italic>
###xml 124 130 124 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H2-Q1 </italic>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 336 342 336 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H2-Q1 </italic>
###xml 425 431 425 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H2-Q1 </italic>
###xml 562 563 562 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 565 570 565 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H2-K1</italic>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
The second gene with profound differential expression was H2-Q1, with a 29.3-fold lower level in the islets from BLKS mice. H2-Q1 localizes to the H2 locus in mice on chromosome 17. B6 mice are known to be isogenic for the H2b haplotype and BLKS mice are a recombinant congenic strain carrying the H2d haplotype [28]. The difference in H2-Q1 expression likely represents a difference conferred by the two haplotypes, and the H2-Q1 gene is possibly not expressed in mice with the H2d haplotype. Furthermore, another gene from the H2 locus was identified in Table 2 (H2-K1), and suggests that the influence of H2 haplotype can manifest in multiple gene expression differences.
###end p 34
###begin p 35
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt</italic>
###xml 131 137 <span type="species:ncbi:9606">humans</span>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
In further studies, we focused on the two genes Plagl1 and Nnt, which have previously been implicated in islet dysfunction in both humans and mice.
###end p 35
###begin title 36
###xml 31 38 31 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt</italic>
Transcriptional differences in Plagl1 and Nnt
###end title 36
###begin p 37
###xml 81 88 81 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 267 274 267 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 697 704 697 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 835 841 835 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1</italic>
###xml 881 883 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 908 915 908 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 935 937 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 969 976 969 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 1077 1084 1074 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 1221 1228 1218 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 1322 1329 1319 1326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 1437 1439 1434 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 1648 1655 1645 1652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 1987 1994 1984 1991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 2065 2067 2062 2064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 308 313 <span type="species:ncbi:9606">human</span>
###xml 756 761 <span type="species:ncbi:9606">human</span>
###xml 779 783 <span type="species:ncbi:10090">mice</span>
###xml 807 812 <span type="species:ncbi:9606">human</span>
###xml 1053 1057 <span type="species:ncbi:10090">mice</span>
###xml 1067 1071 <span type="species:ncbi:10090">mice</span>
###xml 1335 1339 <span type="species:ncbi:10090">mice</span>
###xml 1346 1350 <span type="species:ncbi:10090">mice</span>
###xml 1846 1850 <span type="species:ncbi:10090">mice</span>
###xml 1926 1931 <span type="species:ncbi:9606">human</span>
###xml 2002 2007 <span type="species:ncbi:9606">human</span>
###xml 2012 2016 <span type="species:ncbi:10090">mice</span>
###xml 2193 2197 <span type="species:ncbi:10090">mice</span>
The second-most highly expressed gene in BLKS islets compared with B6 islets was Plagl1 (7.2-fold higher expression; Table 2). The expression state and magnitude was confirmed by qRT-PCR under the same conditions of high glucose in a separate experiment (Figure 3A). Plagl1 has been previously implicated in human transient neonatal diabetes mellitus (TNDM) [29], and can result from paternal uniparental disomy of chromosome 6, or paternal duplication of 6q24 (the TNDM locus). These genetic aberrations suggest the disease results from over-expression of an imprinted gene [29]. If BLKS islets are indeed predisposed to failure (when confronted with insulin resistance), then over-expression of Plagl1 would be consistent with the expression observed in human TNDM. Similarly, mice which over-express the human TNDM locus (including Plagl1) exhibit impaired glucose homeostasis [30]. Several functions for Plagl1 have been reported [31]. Interestingly, evidence that Plagl1 can regulate apoptosis may be relevant to the beta-cell dysfunction in these mice. In BLKS mice, the Plagl1 gene is within a locus predicted to be inherited from the DBA parental strain. To investigate the underlying cause for the difference in Plagl1 expression we sequenced the four exons of the gene. Contrary to the published DNA sequence of Plagl1 in B6 mice, BLKS mice have 16 synonymous polymorphisms and a two-amino acid deletion (623Glu-624Pro; Figure 3B). These polymorphisms are contained within the third exon of the gene. The 16 synonymous polymorphisms may not affect the function of the protein, but could perhaps contribute to the higher expression of the Plagl1 transcript by affecting RNA stability. Additionally the 6 bp deletion could alter the RNA stability or possibly change the function of the protein product. The 623Glu-624Pro deletion in BLKS mice lies at the end of a repetitive Pro-Glu-Gln repeat region not found in the human paralog. Despite this structural difference within the Plagl1 gene of human and mice, functional differences have not been observed [31]. Thus it is uncertain whether the deletion of the 623Glu-624Pro is functionally relevant to the beta-cell phenotype in BLKS mice.
###end p 37
###begin p 38
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 99 100 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 547 551 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 670 674 670 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 883 885 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1002 1006 1002 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 1121 1125 1118 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 1176 1180 1173 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 1228 1230 1225 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1245 1254 1242 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1331 1335 1328 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 1420 1422 1417 1419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1435 1439 1432 1436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
###xml 1150 1154 <span type="species:ncbi:10090">mice</span>
We observed three different probes for Nnt that all showed a clear difference in expression (Table 2). On average, the Nnt was expressed at 4-fold higher levels in BLKS islets in high-glucose conditions. It was observed that the differences in Nnt expression were present in islets cultured in low-glucose conditions (Table 2, column 4); however, this was greater in islets following a stimulated pretreatment. B6 mice were recently shown to be glucose intolerant, as a result of impaired insulin secretion, and this was linked to mutation of the Nnt gene [32]. In this study, a quantitative trait locus (QTL) analysis in B6 and C3H/HeH mice revealed that expression of Nnt was 5-fold lower in B6 islets, and is similar with the 4-fold level we observed compared with BLKS islets. Nnt is a nuclear-encoded mitochondrial protein involved in detoxification of reactive oxygen species [33], which is crucial for their removal and to reduce their deleterious effect on mitochondrial ATP production. Intact Nnt will likely lead to higher ATP levels and thus enhanced insulin secretion in the beta cell. To confirm the role of Nnt in insulin secretion, B6 mice were rescued with an Nnt transgene which improved the insulin secretion [34]. Furthermore,in vitro analyses using insulin-secreting Min6 cells and isolated islets with reduced Nnt function demonstrated diminished insulin secretion associated with lower ATP levels [35]. An intact Nnt gene might be expected to lead to higher ATP levels in BLKS beta cells and thus increased insulin secretion.
###end p 38
###begin p 39
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 212 213 212 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 551 555 551 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 624 626 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 689 691 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1275 1279 1275 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 1410 1414 1410 1414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 1759 1761 1759 1761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1764 1768 1764 1768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 1946 1950 1946 1950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 568 572 <span type="species:ncbi:10090">mice</span>
###xml 632 636 <span type="species:ncbi:10090">mice</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
###xml 886 890 <span type="species:ncbi:10090">mice</span>
###xml 946 950 <span type="species:ncbi:10090">mice</span>
###xml 966 970 <span type="species:ncbi:10090">mice</span>
###xml 1422 1426 <span type="species:ncbi:10090">mice</span>
###xml 1446 1450 <span type="species:ncbi:10090">mice</span>
###xml 1996 2000 <span type="species:ncbi:10090">mice</span>
To investigate the origin of the Nnt gene in BLKS mice, we first investigated its genomic location at 116.1 Mb on chromosome 13 and found that this locus was predicted to be derived from the DBA parental genome [9], suggesting that the gene in BLKS mice was intact. Next, we sequenced the first coding exon, previously reported to contain a point mutation in B6 mice [32]. In DBA mice, codon 35 reads ATG, resulting in methionine, whereas in B6 mice this codon is ACG, resulting in threonine. We found that the DBA strain contributed this exon of the Nnt gene in BLKS mice due to the presence of the ATG at codon 35 (Figure 4A). B6 mice also have a deletion of exons 8 to 11 in this gene [32]. To confirm that the BLKS mice did not carry this multi-exon deletion we performed RT-PCR on islet RNA with primers spanning the deletion (Figure 4B). Corresponding to the intact gene from DBA mice, a 1497 bp amplicon was generated from the DNA of BLKS mice, whereas in B6 mice a smaller 743 bp fragment was observed, as expected, due the deletion. We also observed two smaller fragments of 402 and 598 bp in B6, and inspection of the gene sequence suggests that these fragments are likely a result of the mis-splicing of exon 7 to exons 13 and 14. Altogether, these data show that Nnt is contributed by the DBA strain in BLKS and is intact, in contrast to the disrupted B6 gene. Thus, the higher islet expression of Nnt in BLKS mice relative to the B6 mice is most likely due to the lack of mutation in the DBA-derived allele, and may lead to higher ATP levels and higher insulin secretion, accounting for the enhanced glucose tolerance. Recently a study was published identifying a strong QTL on chromosome 13 governing insulin hypersecretion in a B6 x DBA cross [36]. Nnt was identified as the likely candidate gene and higher gene expression and intact gene structure was observed in islets. These data support our results and confirm the fact that Nnt gene is inherited from the DBA genome in BLKS mice.
###end p 39
###begin p 40
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Nicotinamide nucleotide transhydrogenase is derived from the DBA strain in BLKS mice</bold>
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 350 354 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 527 531 <span type="species:ncbi:10090">mice</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
Nicotinamide nucleotide transhydrogenase is derived from the DBA strain in BLKS mice. (A) Sequencing of exon 1 of the Nnt gene in BLKS and B6 mice confirms the DBA origin of the gene in the BLKS genome. B6 mice possess the codon for threonine (Thr) at residue 35, whereas the BLKS mice have the codon for methionine (Met). (B) RT-PCR analysis of the Nnt RNA in B6 and BLKS. A smaller RT-PCR fragment is amplified from B6 RNA (743 bp) than BLKS RNA (1798 bp), confirming the deletion of exons 8 to 11 previously described in B6 mice [32]. The two smaller bands (bracket) in B6 mice are likely mis-splicing artifacts from downstream exons which are flanked by the PCR primers. M - marker.
###end p 40
###begin p 41
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 605 609 599 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 673 679 667 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1</italic>
###xml 264 269 <span type="species:ncbi:9606">human</span>
###xml 277 282 <span type="species:ncbi:10090">mouse</span>
The observations of altered expression of Plagl1 and Nnt between these two strains could account for the phenotypic differences observed in insulin-resistant states, such as enforced by deficiency of leptin or its receptor. Their individual prior association with human and/or mouse diabetes suggest these genes are functionally relevant to the proper action or survival of the beta cell. The expression differences of these two genes alone may possibly be sufficient to elicit a physiological effect through their interaction. Indeed, the elevated secretion of insulin expected in beta cells with intact Nnt function may precipitate an apoptotic event in a pro-apoptotic, Plagl1-enriched cell.
###end p 41
###begin title 42
Expression differences are mainly contributed by the DBA loci
###end title 42
###begin p 43
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 182 189 182 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 382 383 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 451 452 451 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
We hypothesized that the DBA genome contributes to the islet dysfunction. The locations of the DBA blocks in the BLKS genome have been mapped by other groups [9-11]. We noticed that Plagl1 and Nnt were located in DBA loci of the BLKS genome, and investigated the genetic origin of the other genes in Table 2. We found that 28 out of these 32 genes were derived from DBA loci (Table 2, last three columns), based on the genetic mapping of Davis et al [9].
###end p 43
###begin p 44
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 168 174 168 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Other </italic>
###xml 180 186 180 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Other </italic>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 525 526 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 601 609 601 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">unmapped</italic>
###xml 717 718 717 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 781 787 781 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Other </italic>
###xml 1044 1045 1044 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1353 1359 1353 1359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Other </italic>
###xml 1502 1508 1502 1508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Other </italic>
###xml 860 865 <span type="species:ncbi:10090">mouse</span>
We extended these observations of genomic location and expression fold change to the entire genome. Using the published mapping data [9] we identified the B6, DBA, and Other loci. Other loci were informative regions, but not classifiable as either B6 or DBA. Within these loci we mapped all the probes used in the profiling experiment and combined these data (Additional file 1, supplemental figure). All of the probes were segregated into genome sets, based on location of parental genomes (as described for Additional file 1, supplemental figure). Not all probes could be mapped and were labeled as unmapped, due to the inability to assign probes in intervals between markers derived from different strains. Figure 5 shows the fold changes of the probe sets from the B6, DBA and Other genomes. Microarray probes appear to be uniformly distributed across the mouse genome, and among the haplotype blocks. As the threshold increases, the contribution of the B6 genome declines, and no differences above a threshold of 3.5 were detected (Figure 5). In contrast to the B6 contribution, the contribution of the DBA genome increases as the fold change cut-off increases. At a 2-fold change or greater cut-off, we observed that 75% of the probes were DBA in origin, representing 10 times as many B6 probes. Furthermore, these data show a contribution of the Other genome within the range of 2 to 4-fold; up to 23% of the probes with a fold change greater than or equal to four are from genes located in the Other genome.
###end p 44
###begin p 45
###xml 0 97 0 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Gene expression differences in BLKS islets demonstrate a major contribution by DBA located probes</bold>
###xml 207 213 207 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Other </italic>
###xml 317 318 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 340 342 340 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
Gene expression differences in BLKS islets demonstrate a major contribution by DBA located probes. Gene expression fold-change differences for all probes in the experiment were assigned to either B6, DBA or Other genomes based on chromosomal location. The percentage of probes greater than the fold change threshold (t) are plotted against t for each set of genomically assigned probes. The contributions at a threshold of 1 reflect the baseline genomic contribution of these probes. As the fold change threshold increases, the B6 differences sharply decline, whereas the DBA probes increase their contribution. Above a fold change of 4.5, all of the expression differences are accounted for by DBA assigned probes.
###end p 45
###begin p 46
###xml 314 320 314 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Other </italic>
###xml 324 326 322 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 336 338 334 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 345 348 343 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-27</sup>
###xml 379 381 377 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 388 390 386 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-6</sup>
###xml 593 594 591 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 956 958 954 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1186 1188 1184 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 827 832 <span type="species:ncbi:10090">mouse</span>
###xml 931 935 <span type="species:ncbi:10090">mice</span>
We used the Kruskal-Wallis test to determine if there was a statistical difference in global gene expression fold-change distributions between probes from the different genomes. At the level of the whole genome, we found there was very high statistical significance for fold-change differences between DBA, B6 and Other (chi2 = 126.52, P < 4x 10-27, for probes with significant [P < 1x 10-6] fold changes). We also investigated each chromosome individually using the same test, and found that many chromosomes showed significant differences in fold change between block types (Additional file 1, supplemental table). Chromosomes 6, 7, 8, 13 and 17 were all significant for fold-change distribution differences between the genomes. These data indicate an association of the DBA loci with the gene expression differences in BLKS mouse islets. In a QTL screen to identify loci which influence metabolic phenotypes between B6 and BLKS mice, Mu and colleagues [37] identified two suggestive LOD scores for plasma glucose on chromosomes 8 and 17, both identified in our study to harbor significant gene expression differences. Additionally, the recent report by Aston-Mourney and co-workers [36] identified suggestive LOD scores for insulin secretion on chromosomes 5, 6 and 7, of which two were identified in our study.
###end p 46
###begin title 47
Conclusion
###end title 47
###begin p 48
###xml 357 361 357 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lcn2</italic>
###xml 363 367 363 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spp1</italic>
###xml 369 375 369 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S100a9</italic>
###xml 381 387 381 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc7a3</italic>
###xml 622 629 622 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 633 636 633 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt</italic>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 858 862 <span type="species:ncbi:10090">mice</span>
We have analyzed the physiological differences between B6 and BLKS mice with attention to their glucose homeostasis/islet phenotype. We have shown several transcriptional differences linked to diabetes and inflammatory mechanisms leading to islet damage. Glucose stimulation appears to elicit inflammatory responses, and particularly increases in the genes Lcn2, Spp1, S100a9, and Slc7a3. These changes are seen in both strains, but expression is always higher in BLKS mice. Altogether this suggests that islet dysfunction in BLKS has a strong inflammatory component. The largest islet gene expression differences were in Plagl1 and Nnt, two genes implicated in beta-cell biology. We identified genetic differences in these genes between the two strains. The interaction of these two genes may account for the beta-cell dysfunction commonly observed in BLKS mice. Lastly, we undertook a genomic approach to translate islet expression data, and revealed a significant and primary contribution from the DBA genome. These data demonstrate the utility of combining genomic, genetic, and physiological data to aid in the delineation of multi-factorial phenotypes.
###end p 48
###begin title 49
Methods
###end title 49
###begin title 50
Animal studies
###end title 50
###begin p 51
###xml 235 246 235 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ad libitum </italic>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">Mice</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
###xml 887 892 <span type="species:ncbi:10090">mouse</span>
All mice were maintained in accordance with the Institutional Animal Use and Care Committee of Amgen Inc. B6 and BLKS male mice were obtained at 6 weeks of age from The Jackson Laboratory (Bar Harbor, ME). Mice received food and water ad libitum and were maintained on a 12:12 h light-dark cycle (lights on at 6:30 am) and housed one per cage. Fasting (4 h) blood samples (150 mul) were collected from the retro-orbital sinus of non-anesthetized mice into EDTA plasma tubes and blood glucose was measured using a OneTouch Profile glucometer (LifeScan, Milpitas, CA). For GTT, mice were fasted from 9:00 pm to 9:00 am. Blood glucose was measured at 9:00 am, and an intraperitoneal glucose bolus (2 g/kg body weight) was administered to conscious, unrestrained mice. During the GTT, blood glucose was measured at 30, 60 and 120 min. Plasma insulin levels were analyzed using the LINCOplex mouse endocrine immunoassay panel following the manufacturer's instructions (Millipore, St. Charles, MO).
###end p 51
###begin title 52
Pancreatic islet isolation
###end title 52
###begin p 53
###xml 1344 1345 1330 1331 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Pancreatic islets were isolated from 12-week-old mice. After clamping the common bile duct as it joins the intestine, the pancreas was inflated with 5 ml of collagenase type XI (0.6 mg/ml; Sigma-Aldrich, St. Louis, MO) diluted in Hanks balanced salt solution (HBSS; Sigma-Aldrich). The distended pancreas was removed and incubated at 37degreesC for 10 min, and the islets were dispersed by gentle shaking. Enzymatic digestion was stopped by the addition of 45 ml of cold HBSS containing 10%FBS. Two rounds of centrifugation (300x g for 2 min) and washes with fresh HBSS/FBS were carried out, and the islets were resuspended in 10 ml of HBSS/FBS buffer. The slurry was layered on top of a prepared histopaque gradient (comprised of a 10 ml lower layer of Histopaque 1.119, and 10 ml upper layer of Histopaque 1.077; Sigma-Aldrich). Following centrifugation of the gradient at 1000x g for 30 min, the islets were collected from the top of the 1.077 interface, pipetted onto a 70 mum cell strainer, and washed with HBSS/FBS buffer. Finally, the islets were rinsed into a Petri dish, isolated from any contaminating exocrine material visually using a dissecting microscope, and cultured in RPMI-1640 media (Cellgro, University of Miami, FL), supplemented with 10%FBS and 100 U/ml of penicillin, and 100 mug/ml of streptomycin at 37degreesC in 5% CO2. Prior to all experiments, islets were cultured for 48 h in RPMI-1640 media containing 11 mM glucose, and reselected for use based on morphology as assessed with a dissection microscope.
###end p 53
###begin title 54
Glucose-stimulated insulin secretion assay
###end title 54
###begin p 55
###xml 359 360 358 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 362 363 361 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 376 377 375 376 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 380 381 379 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 408 409 407 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 412 413 411 412 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 431 432 430 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 469 470 468 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 475 476 474 475 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 478 484 <span type="species:ncbi:9913">Bovine</span>
###xml 517 520 <span type="species:ncbi:9685">Cat</span>
###xml 762 765 <span type="species:ncbi:9685">Cat</span>
###xml 1255 1260 <span type="species:ncbi:10090">Mouse</span>
###xml 1280 1283 <span type="species:ncbi:9685">Cat</span>
Twenty-four hours prior to the secretion assay, islets were picked into 24-well inserts (Multiwell Insert System, 8.0 mum pore size; BD Biosciences, San Jose, CA) in groups of 10 similarly sized islets and cultured in 1 ml/well RPMI-1640. For the insulin secretion assay, Krebs-Ringer Bicarbonate (KRBH) Buffer was prepared (129 mM NaCl, 4.8 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4.7H2O, 10 mM HEPES, 2.5 mM CaCl2.2H2O and 4.8 mM NaHCO3) and oxygenated for 15 min with 95%O2/5%CO2. Bovine serum albumin (fatty acid-free, Cat. No. A6003; Sigma-Aldrich) at a final concentration of 0.625% was added to the buffer, then the buffer was warmed to 37degreesC and pH adjusted to 7.4 with 5 M NaOH. The islets were starved for one hour at 37degreesC in KRBH + 1 mM glucose (Cat. No. 99-787-CI, Cellgro) by transferring the 24-well insert from the RPMI-1640 culture media to a new 24-well plate containing 1 ml/well KRBH + BSA and 1 mM glucose. The islets were transferred to the experimental plates containing 1 ml/well of KRBH + BSA and 1 mM, 10 mM and 16.7 mM glucose. Following a one-hour incubation at 37degreesC, the insert containing the islets was removed and the buffer plate frozen at -80degreesC. The insulin ELISA was carried out using the Ultra Sensitive Mouse Insulin ELISA kit (Cat. No. 90080; Crystal Chem Inc. Downers Grove, IL). Five microliters of each buffer sample was run in duplicate per assay protocol.
###end p 55
###begin title 56
DNA and RT-PCR analysis
###end title 56
###begin p 57
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
DNA was isolated from tail tissue and used for PCR and direct sequencing analysis of the Nnt gene. RT-PCR using the One-Step System (Invitrogen, Carlsbad, CA) and islet RNA was performed using the oligonucleotides, Nnt forward-TACAAGAGCTGCCGCTTTGGA, and Nnt reverse-AGACCCACTAAAGGTGACTCCG; the product was used for direct DNA sequencing.
###end p 57
###begin title 58
qRT-PCR
###end title 58
###begin p 59
###xml 268 275 266 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 734 746 731 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclophilin </italic>
###xml 145 150 <span type="species:ncbi:10090">mouse</span>
RNA isolation kits from QIAGEN (micro-RNAeasy kit; Valencia, CA) were used to prepare RNA from purified islets with a final eluate of 15 mul per mouse. RNA was quantified using Agilent's 2100 Bioanalyzer (Santa Clara, CA). Real time PCR was performed using 0.2 muM of Plagl1 primer and probe (forward-TCAAGTGCTCGAAGGCTGAGT, reverse-TGTGTGGCCATGTGTCTCATC, probe-FAM-TGGCAAAGCCTTCGTCTCCAAGTATAAGC-BHQ). Primers were derived from different exons to avoid amplification of any residual genomic DNA. The RT-PCR reactions were done using QIAGEN's Quantitect Multiplex RT-PCR kit. The total reaction volume was 20 mul per well and 20 ng RNA per reaction. Eight replicates of islets isolated from B6 and four replicates of BLKS were run with cyclophilin used as the housekeeping gene. Amplification and quantification of PCR products was performed on an ABI Prism 7900 (Applied Biosystems, Foster City, CA). Data were exported into Excel and analyzed using the delta CT method.
###end p 59
###begin title 60
Islet histology
###end title 60
###begin p 61
###xml 508 509 507 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 510 512 509 511 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 257 267 <span type="species:ncbi:10141">guinea pig</span>
###xml 273 278 <span type="species:ncbi:9823">swine</span>
###xml 396 400 <span type="species:ncbi:9925">goat</span>
###xml 406 416 <span type="species:ncbi:10141">guinea pig</span>
###xml 698 704 <span type="species:ncbi:9986">rabbit</span>
###xml 710 715 <span type="species:ncbi:9606">human</span>
###xml 816 820 <span type="species:ncbi:9925">goat</span>
###xml 826 832 <span type="species:ncbi:9986">rabbit</span>
Pancreata were removed and fixed in buffered zinc formalin and embedded in paraffin. Pancreas sections (5 mum) were deparaffinzed, hydrated and blocked for non-specific reactivity with CAS block (Zymed Lab., San Francisco, CA). Sections were incubated with guinea pig anti-swine insulin (A562; DAKO, Carpinteria, CA) at 1:3000 for 45 min at room temperature. Insulin was detected by biotinylated goat anti-guinea pig (BA-7000; Vector Laboratories Inc., Burlingame CA) at 1:100. Slides were quenched with 3% H2O2 and followed with avidin-biotin HRP Complex (Vector Lab., Burlingame CA). Reaction sites were visualized with DAB (DAKO). Next, slides were rinsed with PBS thoroughly and incubated with rabbit anti-human glucagon (A565; DAKO) at 1:800 for 1 h at room temperature. Glucagon was detected by a biotinylated goat anti-rabbit secondary (BA-1000; Vector Lab.) at 1:200 and followed with avidin-biotin alkaline phosphatase complex. Reaction sites were visualized with alkaline phosphatase substrate (Vector Lab.).
###end p 61
###begin title 62
Experimental design for islet expression profiling
###end title 62
###begin p 63
###xml 310 312 310 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 900 905 <span type="species:ncbi:10090">mouse</span>
We investigated gene expression differences in islets from B6 and BLKS mice and between pretreatments in the presence of low (5 mM) and high glucose (20 mM) in the culture media (to simulate basal and stimulated conditions respectively). To provide >85% confidence that each fold change >1.5 was true, we used n = 5 per group. To eliminate differences in gene expression contributed by variation across mice within a group, we did not pool islets from different animals but kept them separate. Islets were then cultured separately for 24 h in RPMI-1640 media containing either 5 mM or 20 mM glucose. At the end of the culture pretreatment, the islets were picked from the culture vessel, rinsed briefly in HBSS/FBS buffer and homogenized in RLT buffer. RNA was prepared using the micro-RNAeasy kit (QIAGEN). On average, 580 ng of total RNA was recovered from the isolated islets from each individual mouse.
###end p 63
###begin title 64
Pancreatic insulin content
###end title 64
###begin p 65
###xml 562 567 <span type="species:ncbi:10090">Mouse</span>
Pancreata were excised and frozen in liquid nitrogen and stored at -80degreesC. Protein content was determined using the BCA Protein Assay Kit (Thermo Scientific Rockford, IL) following homogenization of the pancreata for 2 min at 25 Hz in 1 ml of 0.18 M HCl and 70% ETOH in a TissueLyser (Qiagen Gmbh, Germany). The tissue lysate was clarified for 10 min at 4000 rpm and the supernatant was transferred to a fresh microcentrifuge tube. For the protein assay, the supernatant was 10x diluted in PBS. The insulin content assay was performed using Ultra Sensitive Mouse Insulin ELISA kit (Crystal Chem). The tissue lysate was diluted 1000x and 6000x with sample diluent supplied with the kit before running the assay. All samples for both assays were run in duplicate.
###end p 65
###begin title 66
Expression profiling
###end title 66
###begin p 67
###xml 641 646 <span type="species:ncbi:10090">Mouse</span>
Total RNA was profiled following the Agilent Two-Color Microarray-Based Gene Expression Analysis Protocol v4.0.2. Briefly, 200 ng of total RNA from each sample was separately amplified and labeled with Cy3- and Cy5-labeled CTP (Perkin Elmer; Wellesley, MA) using the Agilent low-input linear amplification kit. Labeled cRNA was purified using the Qiagen RNeasy Mini kit protocol for liquid samples (QIAGEN). Purified cRNA was quantified using the Nanodrop Fluorospectrometer ND-3000 (Wilmington, DE). Similar amounts of Cy3- and Cy5-labeled cRNA were combined and fragmented for 30 min at 60degreesC. The products were hybridized to Agilent Mouse Whole Genome Microarrays, and the resulting array data were extracted using Agilent Feature Extraction Software v8.1.
###end p 67
###begin title 68
Bioinformatic analysis
###end title 68
###begin p 69
Raw data for each array were analyzed with Matlab software (The Mathworks Inc. Natick, MA). Data were not analyzed as dye ratios, but as dye-normalized relative fluorescence units (RFUs). Dye normalization was accomplished by pairing Cy3 and Cy5 values, and determining the effect of dye on RFU magnitude by including dye as a factor in an ANOVA analysis of the binary logarithm-transformed probe intensities, including all two-factor interactions. The other factors in the ANOVA were strain and glucose pretreatment. Found to be significant, the effect of reporter dye was subtracted in a least-squares manner. Ultimately, technical and then biological replicates were averaged prior to fold-change calculations. Raw and normalized data discussed in this publication have been deposited in National Center for Biotechnology Information's Gene Expression Omnibus (GEO, ) and are accessible through GEO Series accession number GSE11257.
###end p 69
###begin p 70
###xml 34 35 34 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 275 280 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Other</italic>
###xml 468 476 468 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Unmapped</italic>
###xml 790 792 790 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 805 806 805 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
Genotyping data from Davis et al [9] were used to divide the genome into DBA and B6 regions. Each region is bordered by two markers for the same strain with no intervening markers of any other strain. Regions with informative SNPs, not attributable to DBA or B6 were labeled Other. Each microarray probe was mapped to a region by determining if its target gene overlapped with any identified region. Probes not mapped to one of the three regions above were labeled as Unmapped. Fold-change distributions of the four classes of probe were compared using the Kruskal-Wallis test, a nonparametric ANOVA testing the hypothesis that groups have the same median fold-change rank. Fold changes were calculated between BLKS and B6 mice under high-glucose conditions, and those with a strain effect P value of < 1 E-6 were used in the test. This test, for differences between regions, was executed for the entire genome and for each chromosome individually.
###end p 70
###begin title 71
Competing interests
###end title 71
###begin p 72
The authors declare that they have no competing interests.
###end p 72
###begin title 73
Authors' contributions
###end title 73
###begin p 74
###xml 261 268 261 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plagl1 </italic>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnt </italic>
###xml 459 462 <span type="species:ncbi:279896?0.3333333333333333|species:ncbi:10794?0.1111111111111111">MMV</span>
AAA carried out the gene expression data analysis, the SNP analysis, and participated in drafting the manuscript. JH did the glucose tolerance testing, the insulin ELISA for islet insulin secretion experiment, the measurement of pancreatic insulin content, the Plagl1 qPCR, and the Nnt RT-PCR. TJ and CL performed the sequencing and related analysis. DJL prepared RNA from islets isolated by JM, MG, and DJL. DMB and MAD carried out the expression profiling. MMV participated in drafting the paper. DJL conceived of the study, participated in its design and coordination, performed experiments and their analysis, and participated in drafting the manuscript. All authors read and approved the final manuscript.
###end p 74
###begin title 75
Supplementary Material
###end title 75
###begin title 76
Additional file 1
###end title 76
###begin p 77
###xml 0 19 0 19 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Supplementary data.</bold>
###xml 235 240 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Other</italic>
Supplementary data. Figure showing location of the probes from the islet expression profiling compared to the genomic location of the contributing genomes. Table showing differences in gene expression between genomic regions (DBA, B6, Other, Unmapped) at the whole genome and chromosomal levels.
###end p 77
###begin p 78
Click here for file
###end p 78
###begin title 79
Acknowledgements
###end title 79
###begin p 80
We would like to thank Dr Russ Cattley and Gwyneth Van for help with immunohistochemistry.
###end p 80
###begin article-title 81
Diabetes mellitus and genetically programmed defects in beta-cell function
###end article-title 81
###begin article-title 82
###xml 55 61 <span type="species:ncbi:10090">murine</span>
Genetic obesity unmasks nonlinear interactions between murine type 2 diabetes susceptibility loci
###end article-title 82
###begin article-title 83
Positional cloning of Sorcs1, a type-2 diabetes quantitative trait locus
###end article-title 83
###begin article-title 84
###xml 78 82 <span type="species:ncbi:10090">mice</span>
Temporal changes in pancreatic islet composition in C57BL/6J-db/db (diabetes) mice
###end article-title 84
###begin article-title 85
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. III. Effect of H-2 haplotype and sex
###end article-title 85
###begin article-title 86
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure
###end article-title 86
###begin article-title 87
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Alteration of islet cell populations in spontaneously diabetic mice
###end article-title 87
###begin article-title 88
###xml 114 118 <span type="species:ncbi:10090">mice</span>
Genetic analysis of obesity-induced diabetes associated with a limited capacity to synthesize insulin in C57BL/KS mice: evidence for polygenic control
###end article-title 88
###begin article-title 89
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
Ultrafine mapping of SNPs from mouse strains C57BL/6J, DBA/2J, and C57BLKS/J for loci contributing to diabetes and atherosclerosis susceptibility
###end article-title 89
###begin article-title 90
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Genetic analysis of the diabetes-prone C57BLKS/J mouse strain reveals genetic contribution from multiple strains
###end article-title 90
###begin article-title 91
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
Genomic analysis of the C57BL/Ks mouse strain
###end article-title 91
###begin article-title 92
###xml 111 115 <span type="species:ncbi:10090">mice</span>
Glucose homeostasis and tissue transcript content of insulin signaling intermediates in four inbred strains of mice: C57BL/6, C57BLKS/6, DBA/2, and 129X1
###end article-title 92
###begin article-title 93
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
The influence of genetic background on the induction of oxidative stress and impaired insulin secretion in mouse islets
###end article-title 93
###begin article-title 94
Leptin induces inflammation-related genes in RINm5F insulinoma cells
###end article-title 94
###begin article-title 95
###xml 82 85 <span type="species:ncbi:10116">rat</span>
Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat
###end article-title 95
###begin article-title 96
Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
###end article-title 96
###begin article-title 97
Presence of MRP8 and MRP14 in pancreatic cell lines: differential expression and localization in CFPAC-1 cells
###end article-title 97
###begin article-title 98
The calcium-binding protein S100A9 is essential for pancreatic leukocyte infiltration and induces disruption of cell-cell contacts
###end article-title 98
###begin article-title 99
A case with transient increases in serum S100A8/A9 levels implying acute inflammatory responses after pancreatic islet transplantation
###end article-title 99
###begin article-title 100
###xml 52 56 <span type="species:ncbi:10116">rats</span>
Excessive islet NO generation in type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1
###end article-title 100
###begin article-title 101
Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis
###end article-title 101
###begin article-title 102
###xml 49 55 <span type="species:ncbi:9606">humans</span>
TXNIP regulates peripheral glucose metabolism in humans
###end article-title 102
###begin article-title 103
Controlling the false discovery rate: a practical and powerful approach to multiple testing
###end article-title 103
###begin article-title 104
###xml 93 101 <span type="species:ncbi:9606">patients</span>
Progression of diabetic nephropathy enhances the plasma osteopontin level in type 2 diabetic patients
###end article-title 104
###begin article-title 105
Osteopontin protects the islets and beta-cells from interleukin-1 beta-mediated cytotoxicity through negative feedback regulation of nitric oxide
###end article-title 105
###begin article-title 106
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice
###end article-title 106
###begin article-title 107
###xml 91 96 <span type="species:ncbi:9606">human</span>
Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes
###end article-title 107
###begin article-title 108
On naming H2 haplotypes: functional significance of MHC class Ib alleles
###end article-title 108
###begin article-title 109
The cell cycle control gene ZAC/PLAGL1 is imprinted - a strong candidate gene for transient neonatal diabetes
###end article-title 109
###begin article-title 110
###xml 32 47 <span type="species:ncbi:10090">transgenic mice</span>
###xml 63 68 <span type="species:ncbi:9606">human</span>
Impaired glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus locus, TNDM
###end article-title 110
###begin article-title 111
LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions
###end article-title 111
###begin article-title 112
###xml 86 90 <span type="species:ncbi:10090">mice</span>
A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice
###end article-title 112
###begin article-title 113
Nicotinamide nucleotide transhydrogenase: a link between insulin secretion, glucose metabolism and oxidative stress
###end article-title 113
###begin article-title 114
###xml 132 136 <span type="species:ncbi:10090">mice</span>
Deletion of nicotinamide nucleotide transhydrogenase: a new quantitative trait locus accounting for glucose intolerance in C57BL/6J mice
###end article-title 114
###begin article-title 115
Nicotinamide nucleotide transhydrogenase: a key role in insulin secretion
###end article-title 115
###begin article-title 116
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
Increased nicotinamide nucleotide transhydrogenase levels predispose to insulin hypersecretion in a mouse strain susceptible to diabetes
###end article-title 116
###begin article-title 117
###xml 118 123 <span type="species:ncbi:10090">mouse</span>
Quantitative trait loci analysis for the differences in susceptibility to atherosclerosis and diabetes between inbred mouse strains C57BL/6J and C57BLKS/J
###end article-title 117

